Linezolid toxic optic neuropathy: A case report and review of visual prognosis.

Autor:	Toolan KJ; Department of Ophthalmology, Rush University, Chicago, IL, USA., Fondriest J; Department of Ophthalmology, Rush University, Chicago, IL, USA., Keenan K; Department of Neurological Sciences Faculty and Staff, Rush University, Chicago, IL, USA., Mizen T; Department of Ophthalmology, Rush University, Chicago, IL, USA.; Department of Neurological Sciences Faculty and Staff, Rush University, Chicago, IL, USA., Stosic M; Department of Neurological Sciences Faculty and Staff, Rush University, Chicago, IL, USA.
Jazyk:	angličtina
Zdroj:	American journal of ophthalmology case reports [Am J Ophthalmol Case Rep] 2023 Aug 26; Vol. 32, pp. 101922. Date of Electronic Publication: 2023 Aug 26 (Print Publication: 2023).
DOI:	10.1016/j.ajoc.2023.101922
Abstrakt:	Purpose: To describe a case of linezolid toxic optic neuropathy in a 71-year-old female and review the relevant literature. Observations: An adult female with progressive, symmetric vision loss was hypothesized to have linezolid toxic optic neuropathy. Following cessation of linezolid, the patient experienced improvement in visual function over two months. Conclusions and Importance: Patients diagnosed with linezolid toxic optic neuropathy can expect some return of visual function after cessation. The degree of return does not correlate to the cumulative dose of the drug. The goal of this study was to summarize and add to the current body of literature on the topic. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2023 The Authors. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu